Provided by Tiger Fintech (Singapore) Pte. Ltd.

Terns Pharmaceuticals, Inc.

4.34
+0.08001.88%
Volume:163.56K
Turnover:700.17K
Market Cap:379.05M
PE:-4.02
High:4.35
Open:4.30
Low:4.21
Close:4.26
Loading ...

CFO’s Bold Move: Major Stock Purchase at Terns Pharmaceuticals

TIPRANKS
·
01 Jul

CFO Andrew Gengos Reports Acquisition of Common Shares in Terns Pharmaceuticals Inc

Reuters
·
01 Jul

CEO Amy L. Burroughs Reports Acquisition of Common Shares of Terns Pharmaceuticals Inc

Reuters
·
26 Jun

BRIEF-Terns Pharmaceuticals Says TERN-601 Well-Tolerated With Rapid Dose Titration

Reuters
·
24 Jun

Terns Pharmaceuticals Presents Positive Data From Phase 1 Study of Tern-601 Once-Daily Oral Glp-1R Agonist for Treatment of Obesity at 85TH Annual American Diabetes Association Scientific Sessions

THOMSON REUTERS
·
24 Jun

Terns Pharmaceuticals- Phase 2 Falcon Clinical Trial of Tern-601 Completed Enrollment; 12-Week Data Expected in 4Q 2025

THOMSON REUTERS
·
24 Jun

Terns Pharmaceuticals Inc - Tern-601 Well-Tolerated With Rapid Dose Titration

THOMSON REUTERS
·
24 Jun

Terns Pharmaceuticals Announces Positive Results from Phase 1 Study of TERN-601 at ADA Scientific Sessions, Phase 2 Data Expected by End of 2025

Reuters
·
24 Jun

CFO Andrew Gengos Reports Acquisition of Common Shares in Terns Pharmaceuticals Inc

Reuters
·
17 Jun

Terns Pharmaceuticals Inc. Concluded Annual Meeting of Stockholders

Reuters
·
17 Jun

BUZZ-U.S. STOCKS ON THE MOVE-Vaxart, DoubleVerify, Cracker Barrel

Reuters
·
12 Jun

BUZZ-U.S. STOCKS ON THE MOVE-Quantum computing stocks, Grab Holdings, Talen Energy

Reuters
·
11 Jun

BUZZ-Next-generation obesity drugs in focus at upcoming diabetes meeting, Berenberg says

Reuters
·
11 Jun

Terns Pharmaceuticals Inc. Reveals Presentation Highlighting Upcoming Clinical Data for CML and Obesity Treatments

Reuters
·
06 Jun

Analysts Are Bullish on Top Healthcare Stocks: Eli Lilly & Co (LLY), Terns Pharmaceuticals (TERN)

TIPRANKS
·
20 May

Terns Pharmaceuticals Inc. to Present Preclinical Data on TERN-701 at European Hematology Association Congress

Reuters
·
14 May

Terns Pharmaceuticals Reports Q1 2025 Financial Results

TIPRANKS
·
13 May

Terns Pharmaceuticals Inc expected to post a loss of 29 cents a share - Earnings Preview

Reuters
·
09 May

BRIEF-Terns Pharmaceuticals Files For Mixed Shelf Offering Of Up To $300 Million- SEC Filing

Reuters
·
09 May

Terns Pharma Q1 EPS $(0.26) Beats $(0.28) Estimate

Benzinga
·
09 May